Current Issues and Clinical Evidence in Tumor-Infiltrating Lymphocytes in Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current Issues and Clinical Evidence in Tumor-Infiltrating Lymphocytes in Breast Cancer

Published:2015-08-17 Issue:5 Volume:49 Page:355-363
ISSN:2383-7837
Container-title:Journal of Pathology and Translational Medicine
language:en
Short-container-title:J Pathol Transl Med

Author:

Ahn Sung Gwe,Jeong Joon,Hong SoonWon,Jung Woo Hee

Publisher

The Korean Society of Pathologists and The Korean Society for Cytopathology

Subject

Histology,Pathology and Forensic Medicine

Link

http://www.jpatholtm.org/upload/pdf/jptm-49-5-355.pdf

Reference60 articles.

1. The cancer antigenome

2. Neoantigens in cancer immunotherapy

3. Signatures of mutational processes in human cancer

4. Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

5. Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring histological predictive biomarkers for immune checkpoint inhibitor therapy response in non–small cell lung cancer;Journal of Pathology and Translational Medicine;2024-03-15

2. Precision unveiled: Synergistic genomic landscapes in breast cancer—Integrating single‐cell analysis and decoding drug toxicity for elite prognostication and tailored therapeutics;Environmental Toxicology;2024-03-07

3. Immune characteristics and clinical significance of peripheral blood lymphocytes in breast cancer;BMC Cancer;2024-01-09

4. Implications of tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer: clinical oncologist perspectives;Translational Breast Cancer Research;2024-01

5. The role of tumor-infiltrating lymphocytes in triple-negative breast cancer and the research progress of adoptive cell therapy;Frontiers in Immunology;2023-05-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3